Back to search

Identification of Antigen-Specific IgG in Sera from Patients with Chronic Prostatitis

Data up to Jan 2025

Published2004
Citations55
References43

Total Citations Per Year

Abstract

References (43)

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1991 • 3,493 citations

Human neoplasms elicit multiple specific immune responses in the autologous host.

1995 • 1,097 citations

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

1993 • 986 citations

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.

1994 • 921 citations

Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

1998 • 728 citations

CHIP Is a U-box-dependent E3 Ubiquitin Ligase

2001 • 574 citations

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers

2000 • 435 citations

Characterization of human colon cancer antigens recognized by autologous antibodies

1998 • 335 citations

Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.

2000 • 260 citations

Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy

2001 • 257 citations

Chronic prostatitis: A thorough search for etiologically involved microorganisms in 1,461 patients

1991 • 244 citations

Serological analysis of human tumor antigens: molecular definition and implications

1997 • 216 citations

Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer

1999 • 206 citations

Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.

2000 • 192 citations

Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment

1999 • 191 citations

Naked DNA and Adenoviral Immunizations for Immunotherapy of Prostate Cancer: A Phase I/II Clinical Trial

2000 • 185 citations

PROSTATE HISTOPATHOLOGY AND THE CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME: A PROSPECTIVE BIOPSY STUDY

1999 • 149 citations

Autoimmune prostatitis: Evidence of T cell reactivity with normal prostatic proteins

1997 • 147 citations

Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX

2002 • 135 citations

Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer

2000 • 127 citations

PSA is a candidate self-antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome

2000 • 117 citations

Immunobiology of Human Melanoma Antigens MART-1 and gp100 and their Use for Immuno-Gene Therapy

1997 • 104 citations

Noninflammatory Chronic Pelvic Pain Syndrome: Immunological Study in Blood, Ejaculate and Prostate Tissue<footref rid="foot01"><sup>1</sup></footref>

2001 • 99 citations

Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS)

2002 • 84 citations

ANTIBODY IMMUNITY TO PROSTATE CANCER ASSOCIATED ANTIGENS CAN BE DETECTED IN THE SERUM OF PATIENTS WITH PROSTATE CANCER

2000 • 76 citations

The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma

1999 • 74 citations

cDNA cloning and characterization of a novel nucleolar protein.

1996 • 61 citations

Naturally occurring prostate cancer antigen‐specific T cell responses of a Th1 Phenotype can be detected in patients with prostate cancer

2001 • 57 citations

Exploitation of the Antibody Repertoire of Cancer Patients for the Identification of Human Tumor Antigens

1999 • 50 citations

Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: implications for prostate cancer therapy.

1997 • 45 citations

Immunological alterations in the ejaculate of chronic prostatitis patients: clues for autoimmunity

2003 • 38 citations

Autoantibodies to Prostate Specific Antigen in Patients with Benign Prostatic Hyperplasia

1995 • 35 citations

CD4 and CD8 T-Lymphocyte Recognition of Prostate Specific Antigen in Granulomatous Prostatitis

2004 • 34 citations

Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer

2000 • 30 citations

In vitro and ex vivo expression of nucleolar proteins B23 and p120 in benign and malignant epithelial lesions of the prostate.

1995 • 25 citations

CHIP Is a U-box-dependent E3 Ubiquitin Ligase: IDENTIFICATION OF Hsc70 AS A TARGET FOR UBIQUITYLATION

2001 • 23 citations

Characterization of human colon cancer antigens recognized by autologous antibodies

1998 • 14 citations

Immunological alterations in the ejaculate of chronic prostatitis patients: clues for autoimmunity

2003 • 11 citations

Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment

1999 • 9 citations

Tumor vaccines for the management of prostate cancer.

2000 • 9 citations

ANTIBODY IMMUNITY TO PROSTATE CANCER ASSOCIATED ANTIGENS CAN BE DETECTED IN THE SERUM OF PATIENTS WITH PROSTATE CANCER

2000 • 6 citations

PSA is a candidate self‐antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome

2000 • 5 citations

Autoantibodies to Prostate Specific Antigen in Patients with Benign Prostatic Hyperplasia

1995 • 1 citations

Cited By (0)

No citing papers found in database

Identification of Antigen-Specific IgG in Sera from Patients with Chronic Prostatitis (2004) – Journal of Clinical Immunology | Metascience Observatory Explorer